Cabaletta Bio Presents New Interim Data from the DesCAARTes™ Phase 1 Trial at the 31st EADV Congress
PHILADELPHIA, Sept. 10, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of targeted cell therapies for ...
ClearLight Biotechnologies, Inc., today announced that it has added a customized MuVi SPIM CS Light-Sheet Microscope from Luxendo, a Bruker company, to its portfolio of imaging solutions. ClearLight ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio, a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer, genetic blood disorders and autoimmune diseases, ...
OXFORD, England--(BUSINESS WIRE)--Ochre Bio, a pioneer in chronic liver disease medicine development, has today announced the start of a multi-year data licence agreement with GSK. The partnership ...
Entrepreneur First-backed Juno Bio has launched a home test kit for women wanting to get a better understanding of their vaginal microbiome while also contributing data to further research into ...
- Data Presented at ASH; Company to Host Investor Call on December 10 - CAMBRIDGE, Mass. – December 8, 2014 – bluebird bio, Inc. (Nasdaq: BLUE) today announced data from eight subjects treated with ...
Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Wednesday announced the collection of new data that further reinforces the security and performance of its Intelligent Fingerprinting Drug Screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback